‹ All Posts
Saurabh Tyagi--Clovek,Advisory

24th Jun · SEBI-Registered Analyst

$HONASA

$HONASA acquired a 58% stake in Fluence Pharma, marking its entry into nutraceuticals. This move establishes a subsidiary for science-backed, consumer-focused nutrition solutions in India. The acquisition diversifies its portfolio, expands its wellness offerings, and opens new growth opportunities in the rapidly growing health and nutrition market.

#FundamentalViews#StockInNews#WatchOutFor#MacroViews#EquityResearch
629 likes·69 comments